Advanced kidney cancer refers to a stage of kidney cancer where the disease has spread beyond the kidney to other parts of the body, requiring more complex and aggressive treatment strategies. The Advanced Kidn...
Using Biopsies to Inform Response Characteristics in Kidney Cancer Novel Immunotherapy Trials May Drive Progress in Kidney Cancer Field Kidney Cancer Research Consortium Efforts May Improve Treatment Outcomes Kidney Cancer Research Program May Play Pivotal Role in Advancing Care Connecting With Congress to ...
in adults with the medicine axitinib as your first treatment when your kidney cancer has spread or cannot be removed by surgery (advanced RCC). alone if you are at intermediate-high or high risk of your kidney cancer (RCC) coming back after surgery to: ...
A different approach based on evaluating comorbidities at baseline, risk of drug interactions and the impact of antitumor treatment in patients with polytherapy regimen is discussed. A decision-making algorithm is proposed to facilitate the selection of the best therapy for kidney tumors for a ...
The treatment of metastatic kidney cancer is rapidly evolving with the shift from immune checkpoint inhibitor monotherapy to combination therapy. In 2018, the combination of nivolumab–ipilimumab received regulatory approval and multiple positive clinical trials were reported with combinations of PD-1 or ...
Brian I. Rini, MD, FASCO, Ingram professor of medicine, Division of Hematology Oncology, chief of Clinical Trials, Vanderbilt-Ingram University Cancer Center, discusses efforts to utilize genetic testing to improve treatment selection in renal cell carcinoma (RCC) through the phase 2 OPTIC RCC tri...
Martin H. Voss, MD, an assistant attending at Memorial Sloan Kettering Cancer Center, discusses recent data supporting the use of neoadjuvant therapy in patients with locally advanced kidney cancer.
when your cancer has spread (advanced), or if your cancer has returned. KEYTRUDA may be used alone in adults: if your cancer is shown by a laboratory test to be microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR), and you have received anti-cancer treatment and it...
Advanced drug delivery systems are carriers for a wide range of pharmacotherapies used in many applications, including cancer treatment. The use of such carrier systems in cancer treatment is growing rapidly as they help overcome the limitations associated with conventional drug delivery systems. Some...
The surgery completely remove cancer may be an option or the surgery can be used to remove as much of cancer as possible or make the chemotherapy or the